- Home
- NCPL vs CVM Comparison
NCPL vs CVM Comparison
Compare NCPL & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCPL
- CVM
- Stock Information
- Founded
- NCPL 1984
- CVM 1983
- Country
- NCPL United States
- CVM United States
- Employees
- NCPL N/A
- CVM N/A
- Industry
- NCPL Investment Managers
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NCPL Finance
- CVM Health Care
- Exchange
- NCPL Nasdaq
- CVM Nasdaq
- Market Cap
- NCPL 19.3M
- CVM 19.6M
- IPO Year
- NCPL N/A
- CVM 1987
- Fundamental
- Price
- NCPL $3.33
- CVM $3.98
- Analyst Decision
- NCPL
- CVM
- Analyst Count
- NCPL 0
- CVM 0
- Target Price
- NCPL N/A
- CVM N/A
- AVG Volume (30 Days)
- NCPL 1.1M
- CVM 1.7M
- Earning Date
- NCPL 09-15-2025
- CVM 08-14-2025
- Dividend Yield
- NCPL N/A
- CVM N/A
- EPS Growth
- NCPL N/A
- CVM N/A
- EPS
- NCPL N/A
- CVM N/A
- Revenue
- NCPL $812,612.00
- CVM N/A
- Revenue This Year
- NCPL N/A
- CVM N/A
- Revenue Next Year
- NCPL $101.16
- CVM N/A
- P/E Ratio
- NCPL N/A
- CVM N/A
- Revenue Growth
- NCPL N/A
- CVM N/A
- 52 Week Low
- NCPL $1.41
- CVM $1.98
- 52 Week High
- NCPL $11.90
- CVM $66.60
- Technical
- Relative Strength Index (RSI)
- NCPL 38.02
- CVM 64.82
- Support Level
- NCPL $2.85
- CVM $3.30
- Resistance Level
- NCPL $5.14
- CVM $4.25
- Average True Range (ATR)
- NCPL 1.30
- CVM 0.61
- MACD
- NCPL -0.57
- CVM 0.26
- Stochastic Oscillator
- NCPL 2.80
- CVM 38.83
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.